Are Risk-Based MCED Tests the Future of Cancer Screening?
Swathi Kodaikal, MSc
Done early enough, personalized, patient data-driven multi-cancer screening will save lives. But are we there yet?
Predictions
Multiomic Analyses Identify New Pneumonia Biomarkers
BGI Genomics
Some nine sets of metagenomic and transcriptomic biomarkers outperformed existing clinical prediction models
Fine-Tuning Single-Cell Tumor Profiling to Predict Cancer Outcomes
Swathi Kodaikal, MSc
Newly developed computational tool accurately identifies, characterizes, and differentiates cell types in tumor samples
Researchers Predict Risk for Common Deadly Diseases from Millions of Genetic Variants
Broad Institute of MIT and Harvard
Through this "polygenic risk scoring," researchers can identify people at high risk for disease, even if they don't present other warning signs